Delivery Order SPE2DR25D1017-SPE2DR26F9CAL
- Not listed
- The Defense Logistics Agency awarded a $7,213.21 delivery order contract to AmerisourceBergen Drug Corp for the supply of Arimidex 1 mg tablets (30-count packaging) on December 12, 2025, with completion scheduled for December 15, 2025. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), which carries a ceiling value of $999,999,999.00 and extends through...
- The Defense Logistics Agency awarded a $9,392.18 delivery order to AmerisourceBergen Drug Corp on December 15, 2025, for the supply of Arimidex 1 mg tablets (30-count packages). This competitively awarded, non-set-aside contract is classified as a firm fixed price delivery order with an ultimate completion date of December 16, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $4,389.99 on December 8, 2025, for the supply of Arimidex 1 mg tablets in quantities of 30 units. This competitively awarded, firm fixed-price contract is scheduled for completion by December 9, 2025, with performance taking place at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order carries no set-aside designation, reflecting the contractor's ability to compete in...
- The Defense Logistics Agency awarded a delivery order valued at $6,458.62 to AmerisourceBergen Drug Corp for the supply of Arimidex 1 mg tablets (30-count units) on December 11, 2025, with completion scheduled for December 12, 2025. This is a firm fixed-price delivery order with no set-aside designation, meaning it was competitively awarded. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is a child contract issued...
- The Defense Logistics Agency awarded a $5,731.74 delivery order to AmerisourceBergen Drug Corp for Arimidex 1 mg tablets (30-count) on December 17, 2025, with completion scheduled for December 18, 2025. This competitively awarded, firm fixed-price contract represents a child order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through December 2026. The place of performance is AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a $5,731.74 delivery order to AmerisourceBergen Drug Corp on December 19, 2025, for the supply of Arimidex 1 mg tablets (30-count packaging). The contract utilizes firm fixed pricing and is expected to be completed by December 22, 2025. This is a competitively awarded, non-set-aside delivery order issued under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, a $999.99 billion vehicle designated SPE2DX that...
- The Defense Logistics Agency awarded a delivery order valued at $5,731.74 to AmerisourceBergen Drug Corp for Arimidex 1 mg tablets (30-count packaging) on December 18, 2025, with an ultimate completion date of December 19, 2025. This competitively awarded, firm fixed-price contract contains no set-aside designation and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a child contract under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $16,766.29 to AmerisourceBergen Drug Corp for the supply of Arimidex 1 mg tablets (30-count units) on November 24, 2025, with completion expected by November 25, 2025. This is a firm fixed-price contract with no set-aside designation, indicating it was competitively awarded. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 25, 2025, for the supply of Arimidex 1 mg tablets (30-count packages) with a ceiling value of $11,215.99. This is a firm fixed-price delivery order with an ultimate completion date of November 26, 2025, and represents performance at the contractor's corporate office location in Conshohocken, Pennsylvania. The award was made through open competition with no set-aside designation, reflecting...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $13,616.17 by the Defense Logistics Agency on November 25, 2025, for the supply of Arimidex 1 mg tablets (30-count package). This competitively awarded, firm fixed-price delivery order is not associated with a set-aside designation and is scheduled for completion by November 26, 2025. The award represents a continuation of AmerisourceBergen's...
- SPE2DR25D1017Indefinite Delivery Contract
- SPE2DR25D1017-SPE2DR26F9CALDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 23, 2025, for the supply of Arimidex 1 mg tablets (30-count units) with a ceiling value of $8,162.69. This competitively awarded, firm fixed-price delivery order is set to be completed by December 24, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The contract represents a child order under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999.99 billion comprehensive pharmaceutical supply vehicle valued through December 2026 that enables the contractor to supply medications, medical devices, and healthcare commodities to support military healthcare programs globally. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical vendor for federal medical procurement across the Defense Health System and broader federal healthcare operations. The company's contract portfolio with DLA demonstrates consistent capability to deliver brand-name and generic medications, vaccines, specialty pharmaceuticals, and medical supplies through competitively awarded mechanisms. This award for Arimidex, an aromatase inhibitor commonly used in cancer treatment, exemplifies the contractor's role in supporting military and veteran healthcare supply chains with essential pharmaceutical products across multiple therapeutic domains.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $8.2k | 12/22/25 |